Nuvectra Corporation (NVTR) Misses Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Nuvectra Reports Third Quarter 2016 Financial Results
November 9, 2016 4:01 PM ESTPLANO, Texas, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the third quarter ended September 30, 2016.
Highlights
U.S. Algovita sales organization foundationally established, now covering 42 territoriesVirtis CE mark and FDA regulatory submission filings expected towards year endMedical Advisory Board established, advancing efforts of clinical and educational initiativesScott Drees, Chief Executive Officer of Nuvectra, said, We advanced the build-out of our U.S. sales organization, including sales... More
